Oral decitabine/cedazuridine versus intravenous decitabine for acute myeloid leukaemia: a randomised, crossover, registration, pharmacokinetics study
dc.contributor.author | Geissler, Klaus | |
dc.contributor.author | Koristek, Zdenek | |
dc.contributor.author | del Castillo, Teresa Bernal | |
dc.contributor.author | Novak, Jan | |
dc.contributor.author | Rodríguez-Macías, Gabriela | |
dc.contributor.author | Metzelder, Stephan K. | |
dc.contributor.author | Illés, Árpád | |
dc.contributor.author | Mayer, Jiri | |
dc.contributor.author | Arnan, Montserrat | |
dc.contributor.author | Keating, Mary-Margaret | |
dc.contributor.author | Krauter, Jürgen | |
dc.contributor.author | Lunghi, Monia | |
dc.contributor.author | Fracchiolla, Nicola S. | |
dc.contributor.author | Platzbecker, Uwe | |
dc.contributor.author | Santini, Valeria | |
dc.contributor.author | Sano, Yuri | |
dc.contributor.author | Oganesian, Aram | |
dc.contributor.author | Keer, Harold N. | |
dc.contributor.author | Lübbert, Michael | |
dc.date.accessioned | 2025-02-21T13:11:05Z | |
dc.date.available | 2025-02-21T13:11:05Z | |
dc.date.issued | 2024 | |
dc.date.oa | 2025-06-19 | |
dc.date.pasync | 2025-04-29T23:08:49Z | |
dc.date.updated | 2025-02-21T13:11:05Z | |
dc.description.corrector | kzs | |
dc.identifier.citation | British Journal Of Haematology. -205 : 5 (2024), p. 1734-1745. -Br. J. Haematol. - 0007-1048 | |
dc.identifier.doi | http://dx.doi.org/10.1111/bjh.19741 | |
dc.identifier.issn | 0007-1048 | |
dc.identifier.opac | https://ebib.lib.unideb.hu/ebib/CorvinaWeb?action=cclfind&resultview=long&ccltext=idno+BIBFORM128027 | |
dc.identifier.scopus | 85204628829 | |
dc.identifier.uri | https://hdl.handle.net/2437/387286 | |
dc.identifier.url | https://onlinelibrary.wiley.com/doi/10.1111/bjh.19741 | |
dc.identifier.wos | 001318836700001 | |
dc.language | eng | |
dc.rights.access | open access article | |
dc.rights.owner | szerző | |
dc.subject.mab | Orvostudományok | |
dc.subject.mab | Klinikai orvostudományok | |
dc.title | Oral decitabine/cedazuridine versus intravenous decitabine for acute myeloid leukaemia: a randomised, crossover, registration, pharmacokinetics study | |
dc.type | folyóiratcikk | |
dc.type | idegen nyelvű folyóiratközlemény külföldi lapban |
Fájlok
Eredeti köteg (ORIGINAL bundle)
1 - 1 (Összesen 1)
Nincs kép
- Név:
- FILE_UP_0_Br J Haematol - 2024 - Geissler - Oral decitabine cedazuridine versus intravenous decitabine for acute myeloid leukaemia A.pdf
- Méret:
- 4.95 MB
- Formátum:
- Adobe Portable Document Format
- Leírás:
- kiadói változat